Suppr超能文献

来自嗜热栖热放线菌亚种ATCC 393的重组L-天冬酰胺酶II及其抗癌活性。

Recombinant l-Asparaginase II from subsp. ATCC 393 and Its Anticancer Activity.

作者信息

Aishwarya S Susan, Selvarajan E, Iyappan S, Rajnish K N

机构信息

Department of Genetic Engineering, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, Tamilnadu India.

出版信息

Indian J Microbiol. 2019 Sep;59(3):313-320. doi: 10.1007/s12088-019-00806-0. Epub 2019 Apr 23.

Abstract

l-asparaginases from bacterial origin are employed extensively in leukemic treatment and food industry. The present study focuses on the characterization of the recombinant l-asparaginase II from subsp. ATCC 393 cloned into expression system and purified using Ni-NTA chromatography. The recombinant l-asparaginase as a monomer had a molecular weight of 35 kDa. The enzyme was active from 10 to 80 °C with the optimum at 40 °C. The enzyme retained its activity at 28 °C and 37 °C up to 24 h. The enzyme had optimum pH of 6 and retained 50% activity till 18 h. The K of the recombinant enzyme was 0.01235 mM and V 1.576 mM/min. The half life of recombinant l-asparaginase II in human serum was 44 h and trypsin was for 15 min. The LC-MS/MS analysis revealed the molecular weight of 35,050 and pI of 5.64. The secondary structure prediction using CD spectroscopy for the recombinant enzyme showed 33.5% α-helix, 66.5% turn and 0% β sheets. The cytotoxicity of the recombinant enzyme was analysed against MOLT 3, Jurkat E6.1 and K-562 with the IC 50 value of 30, 62.5 and 50 µg/ml.

摘要

源自细菌的L-天冬酰胺酶广泛应用于白血病治疗和食品工业。本研究聚焦于对克隆到表达系统中并通过镍-氮三乙酸(Ni-NTA)色谱法纯化的来自亚种ATCC 393的重组L-天冬酰胺酶II进行特性分析。重组L-天冬酰胺酶作为单体,分子量为35 kDa。该酶在10至80°C具有活性,最适温度为40°C。该酶在28°C和37°C下活性可保持24小时。该酶的最适pH为6,活性保持50%直至18小时。重组酶的K m为0.01235 mM,V max为1.576 mM/分钟。重组L-天冬酰胺酶II在人血清中的半衰期为44小时,在胰蛋白酶中为15分钟。液相色谱-串联质谱(LC-MS/MS)分析显示分子量为35,050,等电点为5.64。使用圆二色光谱(CD)对重组酶进行二级结构预测显示,α-螺旋占33.5%,转角占66.5%,β-折叠占0%。分析了重组酶对MOLT 3、Jurkat E6.1和K-562的细胞毒性,IC 50值分别为30、62.5和50 μg/ml。

相似文献

1
Recombinant l-Asparaginase II from subsp. ATCC 393 and Its Anticancer Activity.
Indian J Microbiol. 2019 Sep;59(3):313-320. doi: 10.1007/s12088-019-00806-0. Epub 2019 Apr 23.
2
In silico analysis, molecular cloning, expression and characterization of l-asparaginase gene from DSM 20016.
3 Biotech. 2017 Oct;7(5):348. doi: 10.1007/s13205-017-0974-4. Epub 2017 Sep 25.
3
Cloning and characterization of Halomonas elongata L-asparaginase, a promising chemotherapeutic agent.
Appl Microbiol Biotechnol. 2017 Oct;101(19):7227-7238. doi: 10.1007/s00253-017-8456-5. Epub 2017 Aug 11.
4
Anticancer Activity of Extremely Effective Recombinant L-Asparaginase from .
J Microbiol Biotechnol. 2022 May 28;32(5):551-563. doi: 10.4014/jmb.2112.12050.
5
Characterization of a Type II L-Asparaginase from the Halotolerant CH11.
Life (Basel). 2023 Oct 31;13(11):2145. doi: 10.3390/life13112145.
6
Cloning, expression, and characterization of thermophilic L-asparaginase from Thermococcus kodakarensis KOD1.
J Basic Microbiol. 2014 Jun;54(6):500-8. doi: 10.1002/jobm.201300741. Epub 2014 Jan 20.
7
Expression and characterization of recombinant l-asparaginase from Pseudomonas fluorescens.
Protein Expr Purif. 2018 Mar;143:83-91. doi: 10.1016/j.pep.2017.09.009. Epub 2017 Oct 25.
9
Glutaminase free l-asparaginase from Vibrio cholerae: Heterologous expression, purification and biochemical characterization.
Int J Biol Macromol. 2018 May;111:129-138. doi: 10.1016/j.ijbiomac.2017.12.165. Epub 2018 Jan 4.
10
Bioprocessing and purification of extracellular L-asparaginase produced by endophytic and its anticancer activity.
Prep Biochem Biotechnol. 2023;53(6):653-671. doi: 10.1080/10826068.2022.2122064. Epub 2022 Sep 22.

引用本文的文献

1
Desirable L-asparaginases for treating cancer and current research trends.
Front Microbiol. 2024 Mar 13;15:1269282. doi: 10.3389/fmicb.2024.1269282. eCollection 2024.
3
Improving the Acid Resistance of Tannase TanBLp (AB379685) from ATCC14917 by Site-Specific Mutagenesis.
Indian J Microbiol. 2022 Mar;62(1):96-102. doi: 10.1007/s12088-021-00983-x. Epub 2021 Sep 22.
4
Cellular Apoptosis Induced by Deoxynivalenol.
Indian J Microbiol. 2022 Mar;62(1):61-69. doi: 10.1007/s12088-021-00965-z. Epub 2021 Aug 30.
6
Acrylamide in Bakery Products: A Review on Health Risks, Legal Regulations and Strategies to Reduce Its Formation.
Int J Environ Res Public Health. 2021 Apr 19;18(8):4332. doi: 10.3390/ijerph18084332.
8
Toxicity Analysis of Recombinant L-asparaginase I and II in Zebrafish.
Indian J Microbiol. 2020 Dec;60(4):535-538. doi: 10.1007/s12088-020-00890-7. Epub 2020 May 30.

本文引用的文献

2
In silico modelling and molecular dynamics simulation studies on L-Asparaginase isolated from bacterial endophyte of Ocimum tenuiflorum.
Enzyme Microb Technol. 2018 Oct;117:32-40. doi: 10.1016/j.enzmictec.2018.06.005. Epub 2018 Jun 18.
3
Glutaminase free l-asparaginase from Vibrio cholerae: Heterologous expression, purification and biochemical characterization.
Int J Biol Macromol. 2018 May;111:129-138. doi: 10.1016/j.ijbiomac.2017.12.165. Epub 2018 Jan 4.
4
In silico analysis, molecular cloning, expression and characterization of l-asparaginase gene from DSM 20016.
3 Biotech. 2017 Oct;7(5):348. doi: 10.1007/s13205-017-0974-4. Epub 2017 Sep 25.
5
Discovery of human-like L-asparaginases with potential clinical use by directed evolution.
Sci Rep. 2017 Aug 31;7(1):10224. doi: 10.1038/s41598-017-10758-4.
6
Cloning and characterization of Halomonas elongata L-asparaginase, a promising chemotherapeutic agent.
Appl Microbiol Biotechnol. 2017 Oct;101(19):7227-7238. doi: 10.1007/s00253-017-8456-5. Epub 2017 Aug 11.
7
Antibacterial, Anticancer and Neuroprotective Activities of Rare Actinobacteria from Mangrove Forest Soils.
Indian J Microbiol. 2017 Jun;57(2):177-187. doi: 10.1007/s12088-016-0627-z. Epub 2016 Oct 26.
10
Recombinant L-Asparaginase from Zymomonas mobilis: A Potential New Antileukemic Agent Produced in Escherichia coli.
PLoS One. 2016 Jun 2;11(6):e0156692. doi: 10.1371/journal.pone.0156692. eCollection 2016.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验